These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2174004)

  • 41. Human PTH(1-34) infusion test in differential diagnosis of various types of hypoparathyroidism: an attempt to establish a standard clinical test.
    Yamamoto M; Furukawa Y; Konagaya Y; Sohn HE; Tomita A; Fujita T; Ogata E
    Bone Miner; 1989 May; 6(2):199-212. PubMed ID: 2548645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of acute hypoxia on phosphate excretion in rats.
    Mimura Y; Knox FG
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R578-83. PubMed ID: 8141418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone-(1-34) administration in normal subjects.
    Slovik DM; Daly MA; Potts JT; Neer RM
    Clin Endocrinol (Oxf); 1984 Apr; 20(4):369-75. PubMed ID: 6325049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Newborn urinary cyclic AMP and developmental renal responsiveness to parathyroid hormone.
    Linarelli LG
    Pediatrics; 1972 Jul; 50(1):14-23. PubMed ID: 4338860
    [No Abstract]   [Full Text] [Related]  

  • 45. Urine calcium excretion, nephrogenous cyclic-adenosine monophosphate and serum parathyroid hormone levels in patients with essential hypertension.
    Papagalanis ND; Skopelitis P; Kourti A; Kostogianni G; Karabatsos A; Gennadiou M; Thomas S; Samartzis M; Mountokalakis T
    Nephron; 1991; 59(2):226-31. PubMed ID: 1659670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A parathyroid hormone inhibitor in vivo: design and biological evaluation of a hormone analog.
    Horiuchi N; Holick MF; Potts JT; Rosenblatt M
    Science; 1983 Jun; 220(4601):1053-5. PubMed ID: 6302844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of parathyroid hormone and calcitonin on stop-flow patterns of cyclic AMP, sodium, potassium, calcium and inorganic phosphate in thyroparathyroidectomized rabbits.
    Tabei K; Asano Y; Imai M
    Miner Electrolyte Metab; 1984; 10(1):36-42. PubMed ID: 6330514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patterns of cyclic 3'5'-adenosine monophosphate excretion in parathyroid dysfunction.
    Ullrich IH; Lizarralde G
    Chronobiologia; 1977; 4(3):199-204. PubMed ID: 202439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased phosphate reabsorption after renal transplantation: Evidence for a mechanism independent of calcium and parathyroid hormone.
    Rosenbaum RW; Hruska KA; Korkor A; Anderson C; Slatopolsky E
    Kidney Int; 1981 Apr; 19(4):568-78. PubMed ID: 6264200
    [No Abstract]   [Full Text] [Related]  

  • 50. The circadian rhythm of intact parathyroid hormone (1-84) and nephrogenous cyclic adenosine monophosphate in normal men.
    Logue FC; Fraser WD; O'Reilly DS; Beastall GH
    J Endocrinol; 1989 Apr; 121(1):R1-3. PubMed ID: 2541215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary excretion and circadian rhythm of cyclic-AMP and cyclic-GMP in childhood.
    Castellote MC; Barberá G; Torralba A
    Rev Esp Fisiol; 1981 Dec; 37(4):403-6. PubMed ID: 6280254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of magnesium depletion on responsiveness to parathyroid hormone in parathyroidectomized rats.
    Hahn TJ; Chase LR; Avioli LV
    J Clin Invest; 1972 Apr; 51(4):886-91. PubMed ID: 4335446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parathyroid hormone and the kidney in pseudohypoparathyroidism.
    Avioli LV
    Prog Biochem Pharmacol; 1980; 17():199-203. PubMed ID: 6259657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary excretion of adenosine 3'5' monophosphate in vitamin D deficiency.
    Vainsel M; Manderlier T; Otten J
    Eur J Clin Invest; 1976 Mar; 6(2):127-30. PubMed ID: 177292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suckling-mediated increases in urinary phosphate and 3',5'-cyclic adenosine monophosphate excretion in lactating rats: possible systemic effects of parathyroid hormone-related protein.
    Yamamoto M; Duong LT; Fisher JE; Thiede MA; Caulfield MP; Rosenblatt M
    Endocrinology; 1991 Nov; 129(5):2614-22. PubMed ID: 1657580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simulation of phosphate excretion by the renal arterial infusion of 3'5'-AMP (cyclic AMP)-a possible mechanism of action of parathyroid hormone.
    Russell RG; Casey PA; Fleisch H
    Calcif Tissue Res; 1968; ():Suppl:54-54a. PubMed ID: 4305495
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of acetazolamide on the urinary excretion of cyclic AMP and on the activity of renal adenyl cyclase.
    Rodriguez HJ; Walls J; Yates J; Klahr S
    J Clin Invest; 1974 Jan; 53(1):122-30. PubMed ID: 4357608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increase of urinary extracellular-superoxide dismutase level correlated with cyclic adenosine monophosphate.
    Adachi T; Yamada H; Hara H; Futenma A; Kakumu S
    FEBS Lett; 1999 Sep; 458(3):370-4. PubMed ID: 10570942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of phosphate depletion and parathyroid hormone on renal glucose reabsorption.
    Harter HR; Mercado A; Rutherford WE; Rodriguez H; Slatopolsky E; Klahr S
    Am J Physiol; 1974 Dec; 227(6):1422-7. PubMed ID: 4374094
    [No Abstract]   [Full Text] [Related]  

  • 60. [Basal excretion and excretion after PTH phosphate and AMPc administration in non-advanced chronic renal failure ].
    Sánchez Rodríguez LM; Rodríguez Commes JL; González Macías J; Sánchez Rodríguez A; Martín Rodríguez M
    Med Clin (Barc); 1982 Jun 16-30; 79(2):65-9. PubMed ID: 6289022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.